General procedure A for the preparation of pyrazolines
A suspension of hydrazine hydrochloride (3.42 g, 0.05 mol, 1 equiv) in MeOH (150 mL) is warmed under inert atmosphere up to 55 °C. Ketone (0.05 mol, 1 equiv) is mixed with the stirred suspension, and subsequently, neat aldehyde (0.05 mol, 1 equiv) is added dropwise to the reaction mixture. The reaction mixture is stirred at 55 ± 5 °C as long as HPLC analysis showed that the reaction is completed (usually 1 h). The final reaction mixture is concentrated to (1 -2 g/g) and after cooling to room temperature the crystallized solid is filtered and washed with MeOH. The solid is dried at 45 °C under vacuum to afford title pyrazoline hydrochloride, which is used directly in the next oxidation step (see general procedure D). If the solid is not formed, the solvent is removed and residue purified by column chromatography silica-gel using DCM/MeOH (3 : 1 v/v) as eluent to afford the pure pyrazoline.
General procedure B for the synthesis of 3,4,5-substituted pyrazoles
A suspension of hydrazine hydrochloride (6.85 g, 0.1 mol, 1 equiv) in MeOH (30 mL) is warmed under inert atmosphere up to 55 °C. Ketone (0.1 mol, 1 equiv) is mixed with the stirred suspension, and subsequently, neat or solid aldehyde (0.1 mol, 1 equiv) is added slowly. The reaction mixture is stirred at 55 ± 5 °C as long as HPLC showed the reaction is completed. The resulted orange solution is cooled to 0 °C over 1 h. Then, bromine (20.8 g, 0.13 mol, 1.3 equiv) is added dropwise to the reaction mixture while stirring at temperature lower than 10 °C. After 30 min of the continuing stirring at 0 -10 °C, the reaction is slowly quenched by 30% aqueous solution of NaOH (53.3 g, 0.4 mol, 4 equiv). The resulted heterogeneous mixture is shortly warmed to 45 -55 °C, cooled to room temperature and stirred overnight. The resulted suspension is filtered and the cake washed with water (60 mL). The collected wet solid is triturated with EtOH (35 mL) at reflux. The mixture is cooled to 0 -10 °C and after more than 1h of stirring filtered. The collected solid is washed with EtOH (4 -6 mL) and dried for 24 h at 65 °C / 2 mbar.
General procedure C for synthesis of 3,5-substituted pyrazoles by catalytic reduction of 4-bromopyrazol intermediates
A suspension of hydrazine hydrochloride (6.85 g, 0.1 mol, 1 equiv) in MeOH (30 mL) is warmed under argon atmosphere to 55 °C. Aryl methyl ketone or alkylmethylketone (0.1 mol, 1 equiv) is mixed with the stirred suspension, then, within 30 min neat aldehyde (0.1 mol, 1 equiv) is added dropwise to the reaction mixture. After 10 min of stirring the resulting orange solution is cooled to 0 °C. Bromine (31.96 g, 0.2 mol, 2 equiv) is added dropwise to the reaction mixture while stirring at temperature lower than 15 °C. After more than 30 min of the continuing stirring at 0 -5 °C the reaction is quenched by slowly (over 1 h ) adding of the 30% aqueous NaOH solution (53.33 g, 0.4 mol, 4 equiv). The resulting heterogeneous mixture is extracted with ethyl acetate (100 mL). From the separated organic layer solvent is removed. The residue is submitted to a catalytic hydrogenation at 4 bar / 80 °C with 5% wet Pd on activated charcoal (3 g, 1.4 mmol, 0.014 equiv) in EtOH (50 mL). After 10 -20 h of hydrogenation, the reaction mixture is cooled, filtered over Celite, the cake is washed with EtOH (50 mL) and from combined mother liquors containing the product solvent is removed in vacuo. The isolated material is hydrobromide salt of pyrazole which is converted to free base by the basic extraction work-up in ethyl acetate/ 10% w/w aqueous solution of sodium carbonate.
General procedure D for the preparation of pyrazoles by oxidation of pyrazolines with oxygen
The solution of pyrazoline (2 mmol) in DMSO (10 mL) is stirred at 85 ± 5 °C under 1 atm of O2 gas for appropriate time. If the starting material is consumed, the reaction solution is cooled to room temperature. After the reaction mixture is poured into the water (200 mL) with stirring, flocculent solid is formed. After one hour, the solid is collected by filtration and washed with water. Then the solid is dried under vacuum at 45 °C overnight to afford pyrazole. If no solid is formed the mixture is extracted three times with DCM. The combined organic layers are washed with water, dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue is purified by column chromatography on silica gel using heptane/ethyl acetate as eluent to afford the pure pyrazole. 1-(Methylsulfonyl)-3,5-bis(4-(trifluoromethyl)benzylidene)piperidin-4-one (10). Concentrated 32% hydrochloric acid (0.854 g, 0.0075 mol, 0.0.375 equiv) was diluted with EtOH (10 mL). Following 1-(methylsulfonyl)piperidin-4-one 2 (1.77 g 0.01 mol, 1 equiv), benzaldehyde 8-(1.77 g 0.01 mol, 1 equiv) was added, and the resulted solution was heated to the reflux for 6 h. After cooling, the precipitate was filtered and dried to afford yellow crystalline product 10 (1.68 g, 69%). 1 3-(4-Nitrophenyl)-4,5,6,7-tetrahydro-2H-indazole (14f). Title compound 14f was prepared according to the procedure B from hydrazine hydrochloride (3.43 g, 0.05 mol, 1 equiv), 4-nitrobenzaldehyde (7.56 g, 0.05 mol, 1 equiv), and cyclohexanone (4.91 g, 0.05 mol, 1 equiv) in EtOH (40 mL). After recrystallization of raw material in EtOH, product 14f (9.98 g, 74%) was isolated as orange solid. 1 Methoxyphenyl)-6-methyl-4,5,6,7-tetrahydro-1H-indazole (14k) . Title compound 14k was prepared according to the general procedure B from 3-methylcyclohexanone, pmethoxybenzaldehyde and hydrazine monohydrochloride as white powder (18.4 g, 76%) . 1 1S,2S,10S,13R,14S,17R,18R)-2,18-Dimethyl-17-[(2R)-6-methylheptan-2-yl]-5-phenyl-6,7-diazapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁸]icosa-4,7-diene (14m) . Title compound 14m was prepared in 5 mmol scale according to the procedure B from hydrazine hydrochloride, 5α-cholestan-3-one and benzaldehyde. After 3 days of cyclization pyrazoline was oxidized by bromine. After quenching of final reaction mixture by sodium hydroxide and following filtration off-white 14m (2.15 g 88%) was isolated. 1 
Characterization and synthetic details

3-(4-
3-Ethyl-4,5,6,7-tetrahydro-1H-indazole (14n)
.
5-Methyl-3-phenyl-1H-pyrazole (17a).
From hydrazine hydrochloride (6.85 g, 0.1 mol, 1 equiv), acetone (5.80 g, 0.1 mol, 1 equiv), and benzaldehyde (10.61 g, 0.1 mol, 1 equiv), according to the general method C, hydrobromide of 17a (23.8 g, 95%) was prepared. This material was extracted with ethyl acetate (2 x 25 mL) from 10% solution Na2CO3. From separated organic phase, solvent was removed in vacuo and the residual solid was recrystallized with cyclohexane (35 mL). This procedure afforded free base of 17a (12.65 g, 80%) as off-white powder. 1 H NMR (600 MHz, CDCl3): δ 7.71 (d, J = 7.1 Hz, 2H, 2'), 7.44 (t, J = 7.5 Hz, 2H, 3'), 7.31 (tt, J = 7.4 Hz, J = 1.2 Hz, 1H, 4'), 6.36 (s, 1H, 4), 2.34 (d, J = 0.6 Hz, 3H, CH3-C5). 13 C NMR (150 MHz, CDCl3): δ 128.7 (1' and 3'), 127.9 (4'), 125.6 (2'), 102.1 (4), 11.8 (CH3), C3 and C5 missing. MS (LR-APCI + ): calcd for C10H10N2: 158.1, measured 158.9 (M + H) + . All spectroscopic data were consistent with previously reported data. [7S] 4-Bromo-5-methyl-3-phenyl-1H-pyrazole (17b). Compound 17b was prepared according to the procedure B in 50 mmol scale. Mixture hydrazine hydrochloride, acetone, and benzaldehyde afforded pyrazoline intermediate, which was in situ brominated with 2 equiv of bromine. Oily product 17b (11.23 g, 95%) was isolated after quenching by aqueous sodium hydroxide, solvent removal and extraction work-up with methyl tert-butyl ether from water. 1 , 1H, 4'), 6.25 (br s, 1H, 1), 2.27 (s, 3H, CH3-C5 ). 13 Bromo-3,5-diphenyl-1H-pyrazole (17c) . From hydrazine hydrochloride (3.43 g, 0.05 mol, 1 equiv), acetophenone (6.00 g, 0.05 mol, 1 equiv) and benzaldehyde (5.31 g, 0.05 mol, 1 equiv), according to the general method B (with 2 equiv bromine), raw 17c (18.56 g, assay 67%, 83% assay corrected) was prepared. This material was recrystallized with isopropanol (50 mL) to yield 17c as yellowish powder (8.19 g, 54%) . 1 H NMR (300 MHz, CDCl3/MeOD-d4 9 : 1 v/v): δ 7.79 (d, J = 7.0 Hz, 4H, 2'), 7.49 -7.38 (m, 6H, 3' and 4'. 13 C NMR (75 MHz, CDCl3): δ 128.9 (4'), 128.7 (3' and 1'), 128.1 (2'), 91.1 (4), C3 missing. MS (LR-APCI + ): calcd for C15H11BrN2: 298.0, measured 298.9 (M + H) + , 300.9 (M + 2 + H) + . All spectroscopic data were consistent with previously reported data. [8S] 4-Bromo-5-tert-butyl-3-phenyl-1H-pyrazole (17d). Title compound 17d was prepared according to the procedure B from hydrazine hydrochloride, pinacolone and benzaldehyde. For the oxidation 2 equiv of bromine were used. Raw bromide (11.67 g) was crystallized from reaction mixture. The isolated material was recrystallized in the mixture methanol (20 mL) and water (5 mL) to give 17d as white powder (8.19 g, 74%) . 1 
4-
4-Iodo-5-methyl-3-phenyl-1H-pyrazole (17e).
A suspension of hydrazine hydrochloride (3.42 g, 0.05 mol, 1 equiv) in MeOH (30 mL) was warmed under argon atmosphere to 55 °C. Acetone (3.05 g 0.0525 mol, 1.05 equiv) was mixed with the stirred suspension, and subsequently, neat benzaldehyde (5.31 g, 0.05 mol, 1 equiv) was added dropwise to the reaction mixture within 30 min. After 30 min of continuing stirring, the resulted orange solution was cooled to 0 °C. Iodine monochloride (20.3 g, 0.125 mol, 2.5 equiv) was added dropwise to the reaction mixture while stirring at temperature lower than 15 °C. After 1 h of continuing stirring at 0 -5 °C, the reaction was quenched with the 30% methanolic solution of MeONa (117.04 g, 0.4 mol, 5.5 equiv) at temperature lower than 20 °C. The solvent was partially distilled off from reaction mixture and residuum was mixed with 10% aqueous solution of sodium sulphite (170 mL). The turbid solution was partially neutralised with 32% hydrochloric acid (23.9 g, 0.21 mol, 4.2 equiv) and the resulted two phase mixture was extracted with methyl tert-butyl ether (70 mL). The separated organic layer was washed with water and dried by dry sodium sulphate. After evaporation, oily product 17e (13.52g, 95%) was dissolved with methyl tert-butyl ether (35 mL), and precipitated at 10 -20 °C by with 33% hydrobromide in glacial acetic acid (12.25 g, 0.05 mol, 1 equiv). The precipitation afforded after filtration and drying orange-brown hydrobromide of 17e (12.66 g, 69%). 1 H NMR (300 MHz, DMSO-d6): δ 7.75 (d, J = 7.1, 2H, 2'), 7.48 (t, J = 7.2 Hz, 2H, 3'), 7.40 (t, J = 7.1 Hz, 1H, 4'), 7.33 (br s, 2H, 1 and HBr), 2.26 (s, 3H, CH3-C5). 13 [14S]
